Skip to main content

This job has expired

You will need to login before you can apply for a job.

Associate Medical Director, Early Clinical Development

Employer
Regeneron Pharmaceuticals, Inc.
Location
Tarrytown, NY, United States
Start date
Apr 15, 2019

View more

Discipline
Clinical, Clinical Development
Required Education
Doctorate/PHD/MD
Position Type
Full time
Hotbed
Pharm Country, Best Places to Work

Job Details

Known for its scientific and operational excellence, Regeneron is a leading science-based biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron commercializes medicines for eye diseases, high LDL-cholesterol, and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including oncology, rheumatoid arthritis, asthma, atopic dermatitis, pain, and infectious diseases.

Summary:
Qualified physician or scientist with experience in the pharmaceutical/biotechnoloigy sector, or academic clinical setting. Works with supervisor and other members of the cross-functional study team to author/contribute to early clinical development protocols and facilitate execution of study activities and data summarization. Unique opportunity to work with an expanding study for a rare disease. Experience with Endocrinology, Rheumatology, muscle disease, bone disease, or rare genetic diseases preferred.

Responsibilities:

• Contributes to/leads the cross-functional study team on the following activities, including but not limited to:

• Collaborates on/designs POC-enabling human studies, First-In-Human (FIH) studies, POC (clinical and/or pharmacologic) studies as per clinical strategy.

• Responsible for the relevance and accuracy of medical science underpinning of clinical study based on thorough scientific review and consultation with internal and external experts.
o Reviews, edits and finalizes clinical trial plans
o Organizes and conducts consultations with global opinion leaders

• Reviews and finalizes the medical and scientific portions of clinical study concepts (CSCs) and clinical study protocols (CSPs) and amendments.

• Reviews and edits documents related to trials, such as monitoring plans, SAPs, amendments, IRB/IEC submissions and regulatory submissions.

• Accountable, with input from Clinical Trial Management and Biostatistics and Data Management for timely clinical trial execution and quality of deliverables:
o Leads and supervises the Clinical Team to produce high quality program deliverables on schedule
o Identifies program, trial or data risks, creates and implements mitigation strategies
o Maintains and develops relationship with key study investigators
o Organizes clinical expert consultations, steering committees and data safety monitoring boards as required
o Reports to supervisor and management on clinical trial findings and milestones
o Responsible for the medical content of clinical study reports
o Reviews all medical/scientific publications related to clinical trial

• Analyzes the benefits and risk aspects of an assigned therapeutic candidate:
o Responsible for the analysis of clinical data, including safety monitoring
o Responsible for activities and procedures that ensure patient safety

• Ensures Clinical Team compliance with FDA, EMEA, ICH and GCP guidelines as well as applicable SOPs regarding clinical safety.

• Authors/contributes to clinical sections of communications/documentation for regulatory agencies and may participate in meetings as needed.

• Conducts detailed literature reviews and analysis of development opportunities from mechanistic, pharmacological and clinical development perspectives.

• Working with the ECD&ES Disease Area Lead, takes lead on various collaborations with TFA Research and Regeneron Genetic Center (RGC) colleagues to understand current and emerging targets/molecule program, provide clinical input on potential disease areas/indications, and design clinical experiments that corroborate or inform the biology for decision-making purposes.

Requirements:
Education:

• M.D. degree or M.D./Ph.D. Board Certification/eligibility in a relevant therapeutic area preferred (such as Endocrinology, Rheumatology, Genetics, Rare Disease) along with relevant industry experience

Experience

• 2-4 years prior industry experience or practice experience, preferably in a research/academic setting

• Experience in analysis of clinical and basic research information from a wide range of topics.

• Effective communications (verbal & written) and presentation skills are essential.

• Must be able to work productively in a fast-paced collaborative environment.

• Demonstrated critical thinking skills and sound decision-making

SKC, #LI-SC1, medical director, translational research, early development, Phase 1, FOP, Endocrinoogy, Rheumatology, bone disease, rare disease, medical monitor, clinical research, clinical research physician

This is an opportunity to join our select team that is already leading the way in the Pharmaceutical/Biotech industry. Apply today and learn more about Regeneron's unwavering commitment to combining good science & good business.

To all agencies: Please, no phone calls or emails to any employee of Regeneron about this opening. All resumes submitted by search firms/employment agencies to any employee at Regeneron via-email, the internet or in any form and/or method will be deemed the sole property of Regeneron, unless such search firms/employment agencies were engaged by Regeneron for this position and a valid agreement with Regeneron is in place. In the event a candidate who was submitted outside of the Regeneron agency engagement process is hired, no fee or payment of any kind will be paid.

Regeneron is an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, sexual orientation, gender identity, disability status, protected veteran status, or any other characteristic protected by law.

Company

Regeneron is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to seven FDA-approved treatments and numerous product candidates in development, all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye disease, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, infectious diseases, pain and rare diseases.
 
Regeneron is accelerating and improving the traditional drug development process through our proprietary VelociSuite® technologies, such as VelocImmune® which produces optimized fully-human antibodies, and ambitious research initiatives such as the Regeneron Genetics Center, which is conducting one of the largest genetics sequencing efforts in the world.

Stock Symbol: REGN

Stock Exchange: NASDAQ

FacebookTwitterInstagramYouTube Logo

Company info
Website
Phone
914-847-7000
Location
Corporate Headquarters
777 Old Saw Mill River Road
Tarrytown
New York
10591
United States

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert